A preliminary analysis presented at an American Heart Association hypertension meeting finds that increasing potassium-rich foods as part of the DASH diet does not significantly raise blood potassium to dangerous levels in adults taking several common blood pressure medications. The study also reports no significant changes in kidney function during the intervention period.

The research is presented as an analysis of the randomized GoFresh and GoFresh Rx trials involving Black adults in the greater Boston area with high blood pressure. Participants were assigned to receive weekly DASH-patterned groceries and nutrition counseling or a monetary stipend to buy groceries. Potassium levels were measured at the start and again after 12 weeks.

Both outlets describe the same core finding: despite some blood pressure drugs being associated with higher serum potassium, the DASH diet did not show a clinically concerning potassium increase in this group. Experts cited note that the results address a theoretical concern about potassium-rich diets in patients using medications such as ACE inhibitors, ARBs, and potassium-sparing diuretics, though they emphasize that caution remains for people with advanced kidney disease or elevated baseline potassium. The findings have not yet been published in a peer-reviewed journal, and the study’s population and kidney-risk scope may limit generalizability.